Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Trade this ETF at your broker
Index | ARK Genomic Revolution |
Investment focus | Equity, World, Health Care |
Fund size | EUR 8 m |
Total expense ratio | 0.75% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Actively managed |
Sustainability | Yes |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in EUR) | - |
Inception/ Listing Date | 12 April 2024 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | ARK Invest International |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | Northern Trust International Fund Administration Services (Ireland) Limited |
Investment Advisor | |
Custodian Bank | Northern Trust Fiduciary Services (Ireland) Limited |
Revision Company | Deloitte Ireland LLP |
Fiscal Year End | 1 June |
Swiss representative | 1741 Fund Solutions AG |
Swiss paying agent | TELLCO AG |
Tax data | Bundesanzeiger | |
Germany | 30% tax rebate | |
Switzerland | ESTV Reporting | |
Austria | Tax Reporting Fund | |
UK | UK Reporting |
Indextype | - |
Swap counterparty | - |
Collateral manager | |
Securities lending | No |
Securities lending counterparty |
Twist Bioscience | 9.20% |
Recursion Pharmaceuticals | 7.47% |
CRISPR Therapeutics | 6.57% |
Adaptive Biotechnologies | 5.31% |
Natera | 5.24% |
CareDx | 4.66% |
Veracyte | 4.47% |
Beam Therapeutics | 4.25% |
Guardant Health, Inc. | 3.96% |
Schrodinger | 3.94% |
United States | 88.07% |
Switzerland | 6.57% |
Other | 5.36% |
Health Care | 94.93% |
Technology | 0.57% |
Other | 4.51% |
Broker | Rating | Execution fee | Account fee | |
---|---|---|---|---|
![]() | 0.00€ | 0.00€ | View offer* | |
![]() | 0.00€ | 0.00€ | View offer* | |
![]() | 0.00€ | 0.00€ | View offer* | |
![]() | 1.50€ 1.50% | 0.00€ | View offer* | |
![]() | 2.50€ 2.50% | 0.00€ | View offer* |
Broker | Rating | Order fee | ETF savings plans | |
---|---|---|---|---|
![]() | 0.99€ | 2613 | View offer* | |
![]() | 1.00€ | 2416 | View offer* | |
![]() | 0.00€ | 1639 | View offer* | |
![]() | 0.00€ | 1068 | View offer* | |
![]() | 5.90€ | 1719 | View offer* |
YTD | -6.38% |
1 month | -17.33% |
3 months | -6.82% |
6 months | -9.59% |
1 year | - |
3 years | - |
5 years | - |
Since inception (MAX) | -12.39% |
2024 | - |
2023 | - |
2022 | - |
2021 | - |
Volatility 1 year | - |
Volatility 3 years | - |
Volatility 5 years | - |
Return per risk 1 year | - |
Return per risk 3 years | - |
Return per risk 5 years | - |
Maximum drawdown 1 year | - |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -29.14% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | AAKG | - - | - - | - |
Borsa Italiana | EUR | ARKG | - - | - - | - |
London Stock Exchange | GBX | ARCG | |||
London Stock Exchange | USD | ARKG | |||
SIX Swiss Exchange | CHF | ARKG | |||
XETRA | EUR | AAKG |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Healthcare Innovation UCITS ETF | 942 | 0.40% p.a. | Accumulating | Sampling |
L&G Healthcare Breakthrough UCITS ETF USD Acc | 60 | 0.49% p.a. | Accumulating | Full replication |
L&G Pharma Breakthrough UCITS ETF | 19 | 0.49% p.a. | Accumulating | Full replication |
Harbor Health Care UCITS ETF Accumulating | 15 | 0.89% p.a. | Accumulating | Full replication |
VanEck Genomics and Healthcare Innovators UCITS ETF A | 4 | 0.35% p.a. | Accumulating | Full replication |